What could a low alkaline phosphatase on a comprehensive metabolic panel indicate?

Low Alkaline Phosphatase on a Comprehensive Metabolic Panel

A persistently low alkaline phosphatase (ALP) most commonly indicates hypophosphatasia—a genetic disorder caused by ALPL gene mutations—but you must systematically exclude secondary causes including malnutrition, micronutrient deficiencies, antiresorptive medications, endocrine disorders, and in acute presentations with liver failure, Wilson disease. 1, 2

---

Define "Low" Alkaline Phosphatase

• Persistent low ALP in adults is defined as a serum concentration < 40 IU/L, though some osteoporosis guidelines use a stricter cutoff of < 30 IU/L when screening for hypophosphatasia. 1
• The upper limit of normal (ULN) for ALP varies by laboratory, sex, and age; results should be interpreted as both absolute values and multiples of the ULN. 3
• In children, ALP levels are physiologically 2–3× adult values due to bone growth, so age-appropriate reference ranges are essential. 3

---

Primary Cause: Hypophosphatasia

Clinical Presentation in Adults

• Adults with hypophosphatasia typically present with mild musculoskeletal complaints: skeletal pain, chondrocalcinosis, calcific periarthritis, stress fractures, pseudofractures, and premature loss of primary teeth (often before the usual eruption age). 1, 2, 4
• Bone mineral density (BMD) by DXA is often normal, which can mislead clinicians into dismissing the diagnosis. 5, 4
• Bone turnover markers (P1NP and β-crosslaps) are significantly reduced even when BMD appears normal, reflecting overall suppression of bone remodeling. 5

Diagnostic Confirmation

• Measure serum pyridoxal-5′-phosphate (vitamin B6): markedly elevated levels (often several-fold above normal) substantiate the diagnosis of hypophosphatasia because TNSALP normally degrades this ALP substrate. 1, 2, 4
• Consider bone-specific ALP measurement: levels are typically low (e.g., < 5.3 μg/L) even when total ALP is borderline-normal, and this can unmask cases missed by total ALP alone. 6, 7
• Perform whole-gene sequencing of ALPL when clinical and biochemical findings suggest hypophosphatasia; pathogenic variants confirm the diagnosis. 1, 2
• The magnitude of ALP reduction correlates with clinical severity: severe perinatal and infantile forms show the lowest levels, while adult and odonto forms may have only modest reductions. 7

Critical Management Pitfall

• Avoid bisphosphonates and other antiresorptive therapies in patients with hypophosphatasia, as these agents further suppress already-low bone turnover and can worsen skeletal outcomes. 5, 2

---

Secondary Causes of Low ALP

Medications

• Antiresorptive medications (bisphosphonates, denosumab) can lower ALP levels by reducing osteoblastic activity; review medication history carefully. 3, 1

Nutritional and Metabolic Disorders

• Malnutrition, vitamin deficiencies (especially vitamin D, vitamin C, zinc, magnesium), and severe protein-calorie deficiency can all depress ALP. 2
• Endocrine disorders (hypothyroidism, hypoparathyroidism, glucocorticoid excess) may contribute to low ALP. 2

Wilson Disease (Acute Liver Failure Context)

• In acute liver failure, markedly subnormal serum ALP (typically < 40 IU/L) is characteristic of Wilson disease, accompanied by Coombs-negative hemolytic anemia, coagulopathy, and relatively modest aminotransferase elevations (typically < 2000 IU/L). 1
• An ALP-to-total bilirubin ratio < 2 is highly specific for Wilson disease in this setting and should prompt immediate evaluation for liver transplantation. 1
• Serum copper concentrations are usually ≥ 200 µg/dL (≈ 31.5 µmol/L), and 24-hour urinary copper excretion is markedly elevated; Kayser-Fleischer rings may be absent in approximately 50% of patients presenting with acute liver failure. 1

---

Diagnostic Algorithm for Low ALP

Step 1: Confirm Persistence

• Repeat ALP measurement to confirm that the low value is not a laboratory artifact or transient phenomenon. 2

Step 2: Exclude Secondary Causes

• Comprehensive medication review: check for bisphosphonates, denosumab, and other drugs that suppress bone turnover. 3, 1
• Nutritional assessment: evaluate for malnutrition, vitamin deficiencies (25-hydroxyvitamin D, vitamin C), and mineral deficiencies (zinc, magnesium). 2
• Endocrine evaluation: consider thyroid function tests and parathyroid hormone if clinically indicated. 2

Step 3: Evaluate for Hypophosphatasia

• Measure serum pyridoxal-5′-phosphate (vitamin B6): markedly elevated levels strongly support hypophosphatasia. 1, 2, 4
• Consider bone-specific ALP measurement if total ALP is borderline-normal but clinical suspicion remains high. 6, 7
• Assess for clinical features: skeletal pain, chondrocalcinosis, calcific periarthritis, stress fractures, pseudofractures, premature tooth loss, or "gray gums" in childhood. 1, 2, 4
• Perform ALPL gene sequencing if biochemical and clinical findings suggest hypophosphatasia. 1, 2

Step 4: Special Context—Acute Liver Failure

• If low ALP presents in the context of acute liver failure, immediately calculate the ALP-to-total bilirubin ratio; a ratio < 2 mandates urgent evaluation for Wilson disease and liver transplantation. 1
• Check serum copper, 24-hour urinary copper, and ceruloplasmin; perform slit-lamp examination for Kayser-Fleischer rings. 1

---

Key Takeaways

• Do not dismiss low ALP as benign or a laboratory artifact without confirming persistence and excluding secondary causes; failure to recognize Wilson disease in young adults with acute liver failure and an ALP-to-bilirubin ratio < 2 can delay life-saving transplantation. 1
• Normal BMD does not exclude hypophosphatasia; bone turnover markers and bone-specific ALP are more sensitive indicators of the disorder. 5, 6, 4
• Avoid bisphosphonates and other antiresorptive therapies in patients with hypophosphatasia, as these agents worsen already-suppressed bone turnover. 5, 2
• Measure serum pyridoxal-5′-phosphate (vitamin B6) as the key biochemical test to substantiate hypophosphatasia when ALP is persistently low. 1, 2, 4